After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.
Stocks Info
Kymera Therapeutics Inc is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. The current market capitalization of Kymera Therapeutics Inc is $4.28B. A total of 0.7 million shares were traded on the day, compared to an average of 722.96K shares.
In the most recent transaction, Gollob Jared sold 59,576 shares of KYMR for 61.42 per share on Oct 15 ’25. After the transaction, the Chief Medical Officer now owns 109,992 company shares. In a previous transaction on Oct 15 ’25, Jared Gollob bought 59,576 shares at 58.26 per share.
Among the insiders who sold shares, Gollob Jared disposed of 3,114 shares on Oct 13 ’25 at a per-share price of $60.00. This resulted in the Chief Medical Officer holding 118,359 shares of KYMR after the transaction. In another insider transaction, Albers Jeffrey W. sold 5,000 shares at $59.19 per share on Oct 13 ’25. Company shares held by the Director now total 0.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, KYMR has a high of $63.96 and a low of $19.44.
As of this writing, KYMR has an earnings estimate of -$0.78 per share for the current quarter. EPS was calculated based on a consensus of 19.0 estimates, with a high estimate of $0.18 per share and a lower estimate of -$1.15. The company reported an EPS of -$0.82 in the last quarter
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. KYMR’s latest balance sheet shows that the firm has $442.42M in Cash & Short Term Investments as of fiscal 2021. There were $17.96M in debt and $92.54M in liabilities at the time. Its Book Value Per Share was $13.77, while its Total Shareholder’s Equity was $459.64M.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for KYMR is Buy with a score of 4.87.
